FenoMark Diagnostics AB
FenoMark Diagnostics AB is a spin-out of Karolinska Institutet in Stockholm, Sweden. Cumulatively the founders have more than 4 decades of cancer research experience, with a particular focus on biomarkers discovery using in-house developed state-of-the-art methods.
Vision and mission
Our vision is to become the leading developer of biomarkers for selecting the best therapeutics to help cancer patients worldwide.
We do this by revealing the true phenotype of each cancer using state-of-the-art proteomics and genomics.
Chief Scientific Officer
PhD, M.Sc. (Pharmacy), Researcher Dep.Oncology-Pathology
Head of Clinical Proteomics Mass Spectrometry facility at SciLifeLab.
Over 15 years of experience in cancer therapy and biomarker research at KI and NKI in Amsterdam.
PhD, B.Sc. (Econ.& Bus.Adm.)
Over 10 years of biomedical research at e.g. Yale, KU Leuven and
Previously VP, CSO of FIT Biotech Oy, heading R&D and business development.
Scientific Director of SciLifeLab
WP leader Cancer Core Europe
Key Opinion Leader in Clinical Proteomics with over a 120 academic publications.
With support from
There are no current vacancies at FenoMark Diagnostics AB
For career opportunities at FenoMark Diagnostics AB, please send applications to firstname.lastname@example.org